The Cooper Companies operates through two business units. CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women. The company was founded in 1980 and is based in Pleasanton, California.
COO Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Cooper Companies Inc. To summarize, we found that Cooper Companies Inc ranked in the 32th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 44.5%. As for the metrics that stood out in our discounted cash flow analysis of Cooper Companies Inc, consider:
As a business, COO is generating more cash flow than 70.01% of positive cash flow stocks in the Healthcare.
The business' balance sheet suggests that 12% of the company's capital is sourced from debt; this is greater than only 23.61% of the free cash flow producing stocks we're observing.
COO's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 39.57% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Cooper Companies Inc? See DXCM, GSK, IQV, ZTS, and REGN.
CooperCompanies (COO) today announced it will release second quarter 2020 financial results on Thursday, June 4, 2020, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. A simultaneous webcast of the call will be available through the “Investor Relations” section of the CooperCompanies website at http://investor.coopercos.com and a transcript of the call will be archived on this site for a minimum of 12 months.